The PROTECT 2 Study : Pressure Injury Treatment by Intermittent Electrical Stimulation: A Randomized, Controlled Trial

Description

Multicentered randomized controlled study with adaptive design to evaluate if Intermittent Electrical Stimulation (IES) decreases progression and facilitates healing of pressure injuries for patients with, sacral / ischial pressure injuries.

Conditions

Stage 1 Pressure Ulcer, Stage 2 Pressure Ulcer

Study Overview

Study Details

Study overview

Multicentered randomized controlled study with adaptive design to evaluate if Intermittent Electrical Stimulation (IES) decreases progression and facilitates healing of pressure injuries for patients with, sacral / ischial pressure injuries.

The PROTECT 2 Study: Pressure Injury Treatment by Intermittent Electrical Stimulation: A Randomized, Controlled Trial

The PROTECT 2 Study : Pressure Injury Treatment by Intermittent Electrical Stimulation: A Randomized, Controlled Trial

Condition
Stage 1 Pressure Ulcer
Intervention / Treatment

-

Contacts and Locations

Winston-Salem

Wake Forest Unverisity, Winston-Salem, North Carolina, United States, 27109

Cleveland

Cleveland Clinic Foundation, Cleveland, Ohio, United States, 44195

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Either new or established stage 1 or 2 sacral or ischial pressure ulcer in the ICU or non-ICU environments.
  • * Participants capable of giving informed consent, or if propitiate, participants having an acceptable individual capable of giving consent on the participant's behalf.
  • * Unstable spinal, pelvic, or hip fractures that may be displaced by a forced contraction.
  • * Rhabdomyolysis
  • * Presence of permanent pacemaker or AICD, and for those with external wires after cardiac surgery, those who are using or at high risk for the development of a requirement for an external pacemaker.
  • * Skin breakdown or malignant skin involvement over the gluteal regions that would preclude the use of surface electrodes
  • * BMI \> 40

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

The Cleveland Clinic,

Chase Donaldson, MD, PRINCIPAL_INVESTIGATOR, The Cleveland Clinic

Andrea Kurz, MD, STUDY_CHAIR, The Cleveland Clinic

Study Record Dates

2025-01